$PAYX

MUCCI MARTIN sold $2.7M of PAYX

MUCCI MARTIN sold 25,000 shares of PAYCHEX INC (PAYX) at $109.93 ($2.75M total) on 2026-07-14.

Original reporting
SEC EDGAR · MUCCI MARTIN
Published Jul 15, 2026, 9:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 15, 2026, 9:04 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$PAYX
Neutral
medium confidence
Mentioned
$PAYX
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PAYXNeutralLow
01

Why it matters

This adds a new, dated insider sale datapoint (25,000 shares at $109.93) but does not include any new operational, financial, or regulatory development for Paychex.

02

Market read

Traders may monitor insider activity for sentiment, but the disclosure alone is unlikely to drive a material repricing without accompanying fundamental news.

03

What to watch

No 10b5-1 plan is stated, but the article does not provide context for the director’s cash needs, tax planning, or whether other planned sales occurred.

Relevance 6/10Novelty 3/10Timing: Filed after-hours on 2026-07-15, referencing a sale dated 2026-07-14.

Background

The article is a SEC Form 4 insider transaction disclosure for Paychex director Mucci Martin.

Company-level read

Ticker impact

$PAYXNeutralMedium confidence
Context

Paychex director Mucci Martin filed a Form 4 open-market sale of 25,000 shares at $109.93 on 2026-07-14.

Expected impact

Low likelihood of a sustained price move; any reaction is likely limited to short-term sentiment.

Evidence & confidence

The filing is a Form 4 insider sale, not a buy, and it provides transaction size and price but no new company performance or guidance information.

Market effects

Minimal, as this is company-specific insider activity with no sector-wide signal.

None indicated.

None indicated.

Counterpoint

The sale could be for diversification or liquidity needs and may not reflect a bearish view on Paychex fundamentals.

Key entities

  • PAYX

    Paychex Inc., the company whose director insider sale is disclosed.

  • MUCCI MARTIN

    Paychex director who sold 25,000 shares in an open-market transaction.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$PAYXHighAI 8/10

Paychex (PAYX): The Segment Mix Shift Caught the Street Off Guard, But Guidance Did Not Move

Paychex (PAYX) reported Q1 FY2027 revenue of $1.6B (+6%) and adjusted EPS of $1.34 (+10%), beating estimates. PEO and Insurance Solutions revenue surged 12%, leading to raised full-year PEO guidance. Despite this, the stock sold off, prompting JPMorgan to upgrade to Neutral and raise its price target to $115. Analysts remain divided on the company's segment mix shift and future growth prospects.

$PAYXHighAI 9/10

Paychex Reports $1.63 Billion In Q1 Revenue As Net Income Increases 12% To $429.7 Million

Paychex reported Q1 2027 revenue of $1.63B, up 6% YoY, with net income rising 12% to $429.7M. Growth was driven by payroll, human capital management, and PEO businesses. Operating income increased 14% to $619.2M, while operating margin improved to 38%. The company also reported higher interest income and reduced acquisition-related expenses. Paychex declared $423.6M in dividends and has a $1B share repurchase program.

$PAYXMedAI 8/10

Paychex (PAYX) Beats EPS Estimates, But Slow Growth Weighs on Shares

Paychex (PAYX) reported fiscal Q1 2027 revenue of $1.6B (+6% YoY) and adjusted EPS of $1.34 (+10% YoY), beating estimates. Operating income rose 14% to $619.2M. The company raised guidance for PEO and Insurance Solutions revenue growth to 7-8%. However, total revenue growth outlook remains at 5-6%, and Management Solutions revenue grew just 4%. Shares fell due to slower growth concerns.